FDA
approval
· 2014-10-30
FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
Summary
The FDA approved Allergan's supplemental application for BYSTOLIC (nebivolol hydrochloride).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BYSTOLIC (NEBIVOLOL HYDROCHLORIDE)